Organogenesis Holdings (ORGO) Enterprise Value (2015 - 2026)
Organogenesis Holdings' (ORGO) quarterly Enterprise Value came in at -$92.1 million in Q1 2026, up 16.68% year-on-year from -$78.9 million in Q1 2025, and up 2.37% quarter-over-quarter from -$94.3 million in Q4 2025.
Organogenesis Holdings (ORGO) Enterprise Value (2015 - 2026) Analysis & Trends
Organogenesis Holdings' Enterprise Value history runs 12 years deep, the most recent figure standing at -$92.1 million for Q1 2026.
- On a quarterly basis, Enterprise Value rose 16.68% year-over-year to -$92.1 million in Q1 2026; TTM through Mar 2026 was -$92.1 million, a 16.68% increase from a year earlier, with the FY2025 full-year figure at -$94.3 million, up 30.72% from the prior year.
- Enterprise Value advanced to -$92.1 million in Q1 2026 per ORGO's latest filing, from -$94.3 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$64.4 million in Q3 2025 and bottomed at -$136.2 million in Q4 2024.
- The 5-year median for Enterprise Value is -$94.9 million (2024), against an average of -$97.7 million.
- Across the five-year window, Enterprise Value sank 22080.9% in 2022 and soared 32.19% in 2025, its largest moves.
- Year by year, Enterprise Value stood at -$103.3 million in 2022, then fell by 1.01% to -$104.3 million in 2023, then slumped by 30.49% to -$136.2 million in 2024, then surged by 30.72% to -$94.3 million in 2025, then gained by 2.37% to -$92.1 million in 2026.
- Per Business Quant, the three latest ORGO Enterprise Value figures stand at -$92.1 million (Q1 2026), -$94.3 million (Q4 2025), and -$64.4 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Organogenesis Holdings | 310.55 Mn | 218.45 Mn | 11.46 Mn | -92.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -92.10 Mn |
| Dec 31, 2025 | -94.33 Mn |
| Sep 30, 2025 | -64.37 Mn |
| Jun 30, 2025 | -73.74 Mn |
| Mar 31, 2025 | -110.53 Mn |
| Dec 31, 2024 | -136.15 Mn |
| Sep 30, 2024 | -94.93 Mn |
| Jun 30, 2024 | -90.48 Mn |
| Mar 31, 2024 | -89.35 Mn |
| Dec 31, 2023 | -104.34 Mn |
| Sep 30, 2023 | -98.83 Mn |
| Jun 30, 2023 | -89.51 Mn |
| Mar 31, 2023 | -89.42 Mn |
| Dec 31, 2022 | -103.29 Mn |
| Sep 30, 2022 | -108.02 Mn |
| Jun 30, 2022 | -112.94 Mn |
| Mar 31, 2022 | -108.50 Mn |
| Dec 31, 2021 | -114.53 Mn |
| Sep 30, 2021 | -487,000.00 |
| Jun 30, 2021 | -517,000.00 |